Airway Medix S.A.
AWM.WA · WSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.04 | -0.00 | 0.07 | -0.01 |
| FCF Yield | -24.97% | 20.36% | -9.16% | -28.10% |
| EV / EBITDA | -32.55 | 7.53 | -74.23 | -13.53 |
| Quality | ||||
| ROIC | -18.43% | -38.93% | 195.88% | -285.12% |
| Gross Margin | -75.00% | 0.00% | 0.00% | 233.33% |
| Cash Conversion Ratio | 5.03 | 1.21 | 1.73 | 1.46 |
| Growth | ||||
| Revenue 3-Year CAGR | – | -72.48% | -50.00% | -49.83% |
| Free Cash Flow Growth | -223.74% | 568.77% | 59.93% | -172.83% |
| Safety | ||||
| Net Debt / EBITDA | -8.02 | 1.67 | -37.90 | -7.39 |
| Interest Coverage | -4.16 | -45.66 | -2.69 | -6.07 |
| Efficiency | ||||
| Inventory Turnover | 0.04 | 0.15 | 0.11 | 0.00 |
| Cash Conversion Cycle | 5,130.00 | -7,620.00 | -6,454.29 | -13,020.00 |